by Erika Siren | Jan 23, 2019
September 5th, 2018, marked a momentous day for Canadian health care as Novartis announced Health Canada’s approval of Kymriah™, the first genetically manipulated cell therapy to be approved in Canada. With the ability of CAR Ts like Kymriah to treat and, potentially...
by Sowmya Viswanathan | Jun 26, 2018
Debe Griffin, MSc, ASQ CPGP, has over 20 years of experience in the cell therapy field, both in bench positions and in leadership. Her primary interests are process improvement, quality assurance and regulatory affairs. She is a consultant with FACT Consulting...
by Sowmya Viswanathan | Jun 19, 2018
Debe Griffin, MSc, ASQ CPGP, has over 20 years of experience in the cell therapy field, both in bench positions and in leadership. Her primary interests are process improvement, quality assurance and regulatory affairs. She is a consultant with FACT Consulting...
by Stacey Johnson | May 11, 2018
For Canada to thrive, supporting and training our future work force and leaders is crucial. This can happen in a myriad of ways. For a group of Canadian organizations in the biotherapeutics field, this has taken the form of joining together to host training workshops...
by Stacey Johnson | Apr 13, 2018
For those who aren’t familiar with THIW, there are parties but no films getting their world premieres. The comparison I’m making in the title is to the fact THIW is becoming a must-attend week-long event, with so much going on from morning to night, that serious...
Comments